II. Indications
- 
                          Peptic Ulcer Disease Prevention
                          - See NSAID Gastrointestinal Adverse Effects
- Prevents ulcers in those on NSAIDs chronically
 
- Cervical Ripening agent in Pregnancy Labor Induction
- Termination of Pregnancy (<77 days)
- Early Pregnancy Loss (<84 days)
III. Contraindications
- Factors that increase risk for Uterine Rupture- Prior Cesarean Section
- Multigravida with >=5 prior pregnancies (relative contraindication)
 
IV. Mechanism
- See Prostaglandin
- Misoprostol is a synthetic Prostaglandin E1 (PGE1) Analog- Misoprostol is a pro-drug, that when taken orally is de-esterified to its active acid
- Misoprostol activity as a PGE1 Analog is local at the Uterus and gastric mucosa with non-toxic doses- Contrast with systemic PGE1 effects absent with Misoprostol (e.g. vasodilation, bronchodilation)
 
 
- 
                          Prostaglandin E1 (PGE1) Local Effects- Cervical Ripening and uterine contractions
- Gastric Mucosa Protection by Prostaglandin replacement- Inhibits gastric acid and pepsin secretion (dose dependent)
- Bolsters mucosal resistance to injury
 
 
V. Medications
- Misoprostol (Cytotec) oral tablets: 100 mcg, 200 mcg- Oral tablets may be used intravaginally
 
VI. Dosing: Prevention of NSAID-induced Peptic Ulcer Disease
- See NSAID Gastrointestinal Adverse Effects
- Option 1: 100 to 200 mcg four times daily with food
- Option 2: 200 mcg orally twice daily with food- Better tolerated than four times per day dosing
 
VII. Dosing: Obstetrics and Gynecology
- 
                          Cervical Ripening
                          - See Cervical Ripening for complete protocol
- Misoprostol 50 mcg per vagina every 6 hours (or 25 mcg every 3 hours)
- Monitor for uterine hyperstimulation and Fetal Heart Rate
- Avoid after prior Cesarean Section, Multigravida (>=5 prior pregnancies)- Risk of Uterine Rupture
 
 
- 
                          Early Pregnancy Loss (<84 days) or Termination of Pregnancy (<77 days)- See Early Pregnancy Loss (includes precautions and monitoring protocol)
- See Mifepristone and Misoprostol Protocol for Early Pregnancy Loss
- Misoprostol Dosing Protocol- Vaginal (or rectal)- Place 800 mcg (4 tablets) intravaginally at 24-48 hours after Mifepristone
- Lie supine for 30 minutes after dose
 
- Buccal Dosing may be used in place of vaginal dosing- Place two of the 200 mcg Misoprostol tablets on each side of the mouth (total 800 mcg)
- Allow tablets to dissolve over 30 minutes
 
- Efficacy improves if followed by second dose Misoprostol 800 mcg 4 hours after first
 
- Vaginal (or rectal)
- Strong uterine cramping and heavier Vaginal Bleeding follows Misoprostol dose- Onset within several hours
- Persists for 3-5 hours
- Lighter Vaginal Bleeding may persist for 9-16 days
 
- Adjunctive medications- NSAIDs
- Heating pad
 
 
VIII. Pharmacokinetics
- Rapid oral absorption
- Serum level peaks within 30 min of oral dose
- Elimination half life (including metabolites): <2 hours
IX. Safety
- Pregnancy Category X (aside from peripartum Cervical Ripening, pregnancy loss)
- Avoid in Lactation
X. Adverse Effects
- See Misoprostol Poisoning
- When used orally (poorly tolerated)- Diarrhea
- Nausea
- Vomiting
- Abdominal cramping
- Flatulence
 
- Gynecologic symptoms (800 mcg dosing)- Strong uterine cramping
- Vaginal Bleeding heavier than typical Menses
 
XI. Efficacy: Peptic Ulcer Disease reduction
- Dosing four times daily: 4% Peptic Ulcer Disease recurrence
- Dosing twice daily: 8% Peptic Ulcer Disease recurrence
- Placebo: 16% Peptic Ulcer Disease recurrence
- Reference
XII. Resources
XIII. References
Images: Related links to external sites (from Bing)
Related Studies
| misoprostol (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
| MISOPROSTOL 100 MCG TABLET | Generic | $0.46 each | 
| MISOPROSTOL 200 MCG TABLET | Generic | $0.74 each | 
